Nanalysis Scientific Corp. (FRA:1N1)

Market Cap	12.05M
Revenue (ttm)	25.54M
Net Income (ttm)	-7.58M
Shares Out	n/a
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,931
Average Volume	1,404
Open	0.1040
Previous Close	0.1040
Day's Range	0.1040 - 0.1080
52-Week Range	0.0775 - 0.2540
Beta	n/a
RSI	50.06
Earnings Date	Nov 24, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softwa...

• Industry: Electromedical and Electrotherapeutic Apparatus
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1N1

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.

Financial numbers in CAD